What does Preamble of Right to Try for Individualized Treatments Act do?

This bill proposes to amend the Federal Food, Drug, and Cosmetic Act. The proposed amendment would authorize the use of investigational individualized medical treatments. This authorization applies to patients diagnosed with a life-threatening disease or condition or severely debilitating illness.

What does SHORT TITLE. of Right to Try for Individualized Treatments Act do?

This Act is formally titled the Right to Try for Individualized Treatments Act.

What does USE OF INVESTIGATIONAL INDIVIDUALIZED MEDICAL TREATMENTS BY of Right to Try for Individualized Treatments Act do?

This section amends the Federal Food, Drug, and Cosmetic Act to define and establish eligibility for investigational individualized medical treatments. It defines 'eligible patient' as someone diagnosed with a life-threatening disease or severely debilitating illness who has exhausted approved treatment options and provided informed consent. The definition of 'eligible health care facility' requires operation under a Federal assurance for protection of human subjects. An 'investigational individualized medical treatment' is defined as a drug or biological product based on a patient's unique genomic profile. Manufacturers of investigational individualized medical treatments operating within eligible health care facilities may make such treatments available, but are not required to do so. The section also modifies existing exemptions to include investigational individualized medical treatments.

Back to bills

Right to Try for Individualized Treatments Act

Last updated: 6/8/2026 · Introduced: 6/8/2026

Author: Ron Johnson (R-WI)

TL;DR (AI)

This bill allows patients with life-threatening diseases or severe debilitating illnesses who have exhausted approved treatments to access investigational medical treatments tailored to their unique genomic profile.
The bill defines requirements for both patients and healthcare facilities involved in providing these individualized treatments, including informed consent and adherence to federal human subject protections.
Manufacturers may voluntarily offer these individualized treatments within eligible facilities, but are not mandated to do so.

119th Congressin committeeOfficial page

Verified Votes

No verified votes yet.

Community Votes

No community votes yet. Be the first!

Voting as guest · Sign in for verified votes

Other Sections

Includes provisions on preamble, short title., and 1 more.

3 sections

Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.

Read official text

Want the full experience?

Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.

Create Free Account